QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
QQQ   306.18 (-1.78%)
AAPL   154.50 (+2.44%)
MSFT   258.35 (-2.36%)
META   186.53 (-1.19%)
GOOGL   104.78 (-2.75%)
AMZN   103.39 (-8.43%)
TSLA   189.98 (+0.91%)
NVDA   211.00 (-2.81%)
NIO   11.19 (-6.44%)
BABA   106.33 (-3.11%)
AMD   86.09 (-2.51%)
T   19.83 (-2.22%)
F   13.23 (-7.61%)
MU   62.41 (-1.20%)
CGC   2.92 (-7.01%)
GE   81.96 (-2.36%)
DIS   110.71 (-2.21%)
AMC   6.08 (+0.00%)
PFE   44.06 (-0.63%)
PYPL   85.52 (-1.66%)
NFLX   365.90 (-0.27%)
ETR:GXI

Gerresheimer - GXI Stock Forecast, Price & News

€71.90
+2.25 (+3.23%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
€69.95
€72.00
50-Day Range
€61.35
€72.50
52-Week Range
€46.66
€87.25
Volume
87,992 shs
Average Volume
140,925 shs
Market Capitalization
$2.26 billion
P/E Ratio
24.97
Dividend Yield
1.97%
Price Target
€86.70
GXI stock logo

About Gerresheimer (ETR:GXI) Stock

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Receive GXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GXI Stock News Headlines

“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Gerresheimer AG (GXI.DE)
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Gerresheimer presents strong fourth quarter
GERRESHEIMER AG GERRESHEIMER OR (0NTI.IL)
Gerresheimer With Strong Second Quarter
Gerresheimer Ag share price hits a new 52 week high
Gerresheimer Business Model Robust
Gerresheimer Sets Foundation for Profitable Growth in 2019
See More Headlines
Receive GXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GXI Company Calendar

Today
2/03/2023
Next Earnings (Estimated)
2/15/2023

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10,447
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€86.70
High Stock Price Forecast
€110.00
Low Stock Price Forecast
€65.50
Forecasted Upside/Downside
+20.6%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.72 billion
Cash Flow
€4.84 per share
Book Value
€41.00 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.26 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Dietmar Siemssen (Age 59)
    CEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board
    Comp: $1.91M
  • Dr. Bernd Metzner Ph.D. (Age 52)
    CFO & Member of the Management Board
    Comp: $1.19M
  • Dr. Lukas Burkhardt (Age 43)
    Member of the Management Board
    Comp: $1.16M
  • Ms. Katja Schnitzler (Age 41)
    Member of Supervisory Board
    Comp: $106k
  • Ms. Carolin Nadilo
    Corp. Director of Investor Relations
  • Ueli Utzinger
    Group Sr. Director Marketing & Communication
  • Mr. Helmut Schweiger
    MD & GM of Gerresheimer Horsovsky Tyn Plant













GXI Stock - Frequently Asked Questions

What is Gerresheimer's stock price forecast for 2023?

0 Wall Street analysts have issued 12-month price targets for Gerresheimer's stock. Their GXI share price forecasts range from €65.50 to €110.00. On average, they anticipate the company's stock price to reach €86.70 in the next year. This suggests a possible upside of 20.6% from the stock's current price.
View analysts price targets for GXI
or view top-rated stocks among Wall Street analysts.

How have GXI shares performed in 2023?

Gerresheimer's stock was trading at €62.80 at the start of the year. Since then, GXI shares have increased by 14.5% and is now trading at €71.90.
View the best growth stocks for 2023 here
.

When is Gerresheimer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our GXI earnings forecast
.

Is Gerresheimer a good dividend stock?

Gerresheimer (ETR:GXI) pays an annual dividend of €1.25 per share and currently has a dividend yield of 1.97%. The dividend payout ratio is 43.40%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Gerresheimer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Gerresheimer investors own include Agilent Technologies (A), Abbott Laboratories (ABT), ACADIA Pharmaceuticals (ACAD), AxoGen (AXGN), Biohaven (BHVN), Blueprint Medicines (BPMC), Cree (CREE), Henkel AG & Co. KGaA (HEN3), Sarepta Therapeutics (SRPT) and Alcoa (AA).

What is Gerresheimer's stock symbol?

Gerresheimer trades on the ETR under the ticker symbol "GXI."

What is Gerresheimer's stock price today?

One share of GXI stock can currently be purchased for approximately €71.90.

How much money does Gerresheimer make?

Gerresheimer (ETR:GXI) has a market capitalization of $2.26 billion and generates $1.72 billion in revenue each year.

How many employees does Gerresheimer have?

The company employs 10,447 workers across the globe.

How can I contact Gerresheimer?

Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The official website for the company is www.gerresheimer.com. The company can be reached via phone at +49-211-618100.

This page (ETR:GXI) was last updated on 2/3/2023 by MarketBeat.com Staff